国际医学
(000516)
| 流通市值：104.29亿 | | | 总市值：105.90亿 |
| 流通股本：22.05亿 | | | 总股本：22.39亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 331,072,769.68 | 397,812,399.82 | 471,603,381.91 | 590,562,003.38 |
| 交易性金融资产 | 13,795,860 | 15,335,398 | 15,795,260 | 89,074,177.5 |
| 应收票据及应收账款 | 616,881,093.77 | 594,164,437.89 | 690,857,166.93 | 739,394,118 |
| 应收账款 | 616,881,093.77 | 594,164,437.89 | 690,857,166.93 | 739,394,118 |
| 预付款项 | 19,114,837.65 | 18,838,552.95 | 17,538,655.63 | 14,918,233.92 |
| 其他应收款合计 | 49,289,410.59 | 51,589,526.23 | 52,779,427.21 | 51,207,494.92 |
| 存货 | 75,274,149 | 60,881,548.14 | 63,274,718.58 | 81,005,105.26 |
| 其他流动资产 | 45,439,576.11 | 47,331,265.59 | 45,613,793.28 | 48,913,918.86 |
| 流动资产合计 | 1,150,867,696.8 | 1,185,953,128.62 | 1,357,462,403.54 | 1,615,075,051.84 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,513,962.51 | 1,708,984.08 | 1,943,967.4 | 1,377,139.03 |
| 其他非流动金融资产 | 245,822,813.43 | 253,192,182.01 | 242,698,087.66 | 244,233,241.25 |
| 投资性房地产 | 15,654,858.87 | 15,902,969.37 | 16,071,429.87 | 16,399,190.37 |
| 固定资产 | 6,838,102,473.27 | 6,968,701,386.18 | 7,130,759,271.38 | 7,285,642,716.34 |
| 在建工程 | 344,317,451.56 | 359,639,390.88 | 358,097,896.28 | 328,487,804.34 |
| 无形资产 | 684,750,146.68 | 692,901,964.68 | 701,072,568.01 | 709,814,400.65 |
| 长期待摊费用 | 44,585,004.84 | 45,588,986.11 | 49,752,263.5 | 53,503,044.59 |
| 递延所得税资产 | 71,976,312.29 | 78,827,188.71 | 78,941,868.16 | 79,056,426.69 |
| 其他非流动资产 | 393,065,792.64 | 403,095,491.48 | 382,043,127.05 | 302,732,977.79 |
| 非流动资产合计 | 8,639,788,816.09 | 8,819,558,543.5 | 8,961,380,479.31 | 9,021,246,941.05 |
| 资产总计 | 9,790,656,512.89 | 10,005,511,672.12 | 10,318,842,882.85 | 10,636,321,992.89 |
| 流动负债: | | | | |
| 短期借款 | 994,775,888.9 | 882,326,750.01 | 850,873,159.34 | 823,166,366.96 |
| 应付票据及应付账款 | 1,696,993,740.4 | 1,738,655,943.97 | 1,769,520,432.76 | 1,843,264,695.51 |
| 其中：应付票据 | 46,000,000 | 90,000,000 | 60,000,000 | - |
| 应付账款 | 1,650,993,740.4 | 1,648,655,943.97 | 1,709,520,432.76 | 1,843,264,695.51 |
| 预收款项 | 190,207.71 | 209,366.69 | 526,258.6 | 411,603.1 |
| 合同负债 | 230,420,758.31 | 234,309,292.72 | 231,705,493.35 | 231,254,869.54 |
| 应付职工薪酬 | 165,579,602.55 | 152,683,209.9 | 157,403,234.56 | 218,876,161.02 |
| 应交税费 | 23,718,782.18 | 24,831,076.71 | 19,751,471.73 | 24,556,058.99 |
| 其他应付款合计 | 212,841,791.75 | 179,799,928.87 | 184,578,102.96 | 193,580,373.8 |
| 应付股利 | 1,209,363.18 | 1,209,363.18 | 1,209,363.18 | 1,209,363.18 |
| 一年内到期的非流动负债 | 905,070,397.04 | 997,942,636.01 | 860,900,139.14 | 816,369,733.87 |
| 其他流动负债 | 5,137.18 | 5,551.33 | 4,963.6 | 5,620.05 |
| 流动负债合计 | 4,229,596,306.02 | 4,210,763,756.21 | 4,075,263,256.04 | 4,151,485,482.84 |
| 非流动负债: | | | | |
| 长期借款 | 2,493,642,911.24 | 2,570,997,911.21 | 2,887,370,673.41 | 2,996,791,673.38 |
| 长期应付款 | 99,597 | 99,597 | 99,597 | 99,597 |
| 预计负债 | 5,702,185.66 | 6,194,203.53 | 9,586,483.52 | 8,334,524.94 |
| 递延收益 | 4,945,171.12 | 5,080,224.72 | 5,092,818.65 | 5,220,673.71 |
| 递延所得税负债 | 2,400,000 | 2,400,000 | 2,400,000 | 2,400,000 |
| 非流动负债合计 | 2,506,789,865.02 | 2,584,771,936.46 | 2,904,549,572.58 | 3,012,846,469.03 |
| 负债合计 | 6,736,386,171.04 | 6,795,535,692.67 | 6,979,812,828.62 | 7,164,331,951.87 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,238,896,753 | 2,238,896,753 | 2,260,382,715 | 2,260,382,715 |
| 资本公积 | 971,666,482.14 | 971,655,974 | 1,062,888,908.95 | 1,062,888,908.95 |
| 减:库存股 | - | - | 69,017,805.61 | 69,017,805.61 |
| 盈余公积 | 400,702,384.75 | 400,702,384.75 | 400,702,384.75 | 400,702,384.75 |
| 未分配利润 | -273,684,991.31 | -144,990,278.39 | -86,382,306.78 | 19,971,552.1 |
| 归属于母公司股东权益合计 | 3,337,580,628.58 | 3,466,264,833.36 | 3,568,573,896.31 | 3,674,927,755.19 |
| 少数股东权益 | -283,310,286.73 | -256,288,853.91 | -229,543,842.08 | -202,937,714.17 |
| 股东权益合计 | 3,054,270,341.85 | 3,209,975,979.45 | 3,339,030,054.23 | 3,471,990,041.02 |
| 负债和股东权益合计 | 9,790,656,512.89 | 10,005,511,672.12 | 10,318,842,882.85 | 10,636,321,992.89 |
| 公告日期 | 2025-10-30 | 2025-08-22 | 2025-04-23 | 2025-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |